The DNA testing company, which has 10 million customers, misses nearly 90 percent of people with risky BRCA mutations. It says the criticism is overblown. Source: NYT > Business – HEATHER MURPHY
The DNA testing company, which has 10 million customers, misses nearly 90 percent of people with risky BRCA mutations. It says the criticism is overblown. Source: NYT > Business – HEATHER MURPHY